A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib
Public ClinicalTrials.gov record NCT01387555. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Randomized Trial of JX-594 (Vaccinia GM-CSF / TK-deactivated Virus) Plus Best Supportive Care Versus Best Supportive Care in Patients With Advanced Hepatocellular Carcinoma Who Have Failed Sorafenib Treatment
Study identification
- NCT ID
- NCT01387555
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Jennerex Biotherapeutics
- Industry
- Enrollment
- 129 participants
Conditions and interventions
Conditions
Interventions
- JX-594 recombinant vaccina GM-CSF Biological
- Best Supportive Care Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 7, 2011
- Primary completion
- Sep 30, 2013
- Completion
- Sep 30, 2013
- Last update posted
- Jul 7, 2026
2011 – 2013
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Moores University of California San Diego Cancer Center | La Jolla | California | 92093 | — |
| Chao Family Comprehensive Cancer Center | Orange | California | 92868 | — |
| California Pacific Medical Center | San Francisco | California | — | — |
| Stanford Hospital and Clinics | Stanford | California | — | — |
| University of Chicago Medical Center | Chicago | Illinois | — | — |
| Billings Clinic | Billings | Montana | — | — |
| Saint Joseph's Hospital | Paterson | New Jersey | — | — |
| Montefiore Medical Center | The Bronx | New York | — | — |
| Gabrail Cancer Center | Canton | Ohio | — | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | — | — |
| The Methodist Hospital Department of Surgery | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01387555, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01387555 live on ClinicalTrials.gov.